← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 28, 2010Last known activity
Apr 3, 2025
Timeline
1990s
- Jun 1, 1992
Materia Medica Holding— Founded
Drugs by trial phase (14 distinct, 32 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Indications
Studied for
- Anxiety Disorders
- Atherosclerosis
- Brain Injuries
- Cerebral Infarction
- Cognition Disorders
- Cognitive Dysfunction
- Communicable Diseases
- Developmental Disabilities
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Dyspepsia
- Glucose Intolerance
- Hyperplasia
- Infections
- Influenza, Human
- Intracranial Arteriosclerosis
- Ischemia
- Learning Disabilities
- Lung Diseases
- Lung Diseases, Obstructive
- Neurotic Disorders
- Prostatic Hyperplasia
- Pulmonary Disease, Chronic Obstructive
- Respiratory Tract Infections
- Stroke
- Trematode Infections
- Virus Diseases
- Wounds and Injuries
Recent trials (33)
- NCT06901297Lead sponsorPhase 3Apr 3, 2025
- NCT06715891Lead sponsorPhase 3Sep 29, 2024
- NCT06263881Lead sponsorPhase 3Dec 1, 2023
- NCT06284265Lead sponsorPhase 3Oct 16, 2023
- NCT05364671Lead sponsorPhase 3Apr 29, 2022
- NCT05069649Lead sponsorPhase 3Oct 6, 2021
- NCT04918771Lead sponsorPhase 3Apr 29, 2021
- NCT04250311Lead sponsorPhase 3Dec 12, 2019
- NCT04295681Lead sponsorPhase 3Dec 12, 2019
- NCT04244084Lead sponsorPhase 3Oct 8, 2019
- NCT03815292Lead sponsorPhase 3Oct 19, 2018
- NCT03725033Lead sponsorPhase 3Oct 10, 2018
- NCT03707912Lead sponsorPhase 4Oct 9, 2018
- NCT03485495Lead sponsorPhase 4Apr 12, 2018
- NCT03301155Lead sponsorPhase 4Oct 3, 2017
Details
- Founded
- Moscow, RU Jun 1, 1992
- Last known activity
- Apr 3, 2025